Genetic basis of thoracic aortic aneurysms and aortic dissections

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 139 C, Issue 1, 2005, Pages 10-16

  Pannu, Hariyadarshi ^a   Tran Fadulu, Van ^a   Milewicz, Dianna M ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MSB 4202 ^*  (United States)

Author keywords

Aneurysms; Aorta; Aortic disease; Dissections; FBN1; TGFBR1; TGFBR2; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

AORTA DISSECTION; ASCENDING AORTA; AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; DISEASE COURSE; FAMILIAL DISEASE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; HYPOTHESIS; MARFAN SYNDROME; NONHUMAN; ONSET AGE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THORACIC AORTA; THORACIC AORTA ANEURYSM;

AORTIC ANEURYSM; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; MICROFILAMENT PROTEINS; MUTATION; PENETRANCE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 28444432646     PISSN: 15524868     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.c.30069     Document Type: Review

References (62)

1. Ades LC, Sreetharan D, Onikul E, Stockton V, Watson KC, Holman KJ. 2002. Segregation of a novel FBN1 gene mutation, G1796E, with kyphoscoliosis and radiographic evidence of vertebral dysplasia in three generations. Am J Med Genet 109:261-270.
2. Aoyama T, Francke U, Dietz HC, Furthmayr H. 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenetic mechanisms. J Clin Invest 94:130-137.
3. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. 1997. Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77:31-37.
4. Biddinger A, Rocklin M, Coselli J, Milewicz DM. 1997. Familial thoracic aortic dilatations and dissections: A case control study. J Vasc Surg 25:506-511.
5. Boileau C, Jondeau G, Babron MC, Coulon M, Alexandre JA, Sakai L, Melki J, Delorme G, Dubourg O, Bonaiti-Pellie C. 1993. Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes [see comments]. Am J Hum Genet 53:46-54.
6. Clementi M, Notari L, Borghi A, Tenconi R. 1996. Familial congenital bicuspid aortic valve: A disorder of uncertain inheritance. Am J Med Genet 62:336-338.
7. Coady MA, Davies RR, Roberts M, Goldstein LJ, Kogalski MJ, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA. 1999. Familial patterns of thoracic aortic aneurysms. Arch Surg 134:361-367.
8. Collod G, Babron MC, Jondeau G, Coulon M, Weissenbach J, Dubourg O, Bourdarias JP, Bonaiti-Pellie C, Junien C, Boileau C. 1994. A second locus for Marfan syndrome maps to chromosome 3p24.2-p25 [see comments]. Natl Genet 8:264-268.
9. Corson GM, Chalberg SC, Dietz HC, Charbonneau NL, Sakai LY. 1993. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics 17: 476-484.
10. Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, Fisher I, Lazaridis K, Abraham DJ, Black CM, de Crombrugghe B. 2003. Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J Biol Chem 278:25109-25119.
11. Dietz H, Francke U, Furthmayr H, Francomano C, De Paepe A, Devereux R, Ramirez F, Pyeritz R. 1995. The question of heterogeneity in Marfan syndrome. Natl Genet 9:228-231.
12. Elsheikh M, Casadei B, Conway GS, Wass JA. 2001. Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol (Oxf) 54: 69-73.
13. Faivre L, Gorlin RJ, Wirtz MK, Godfrey M, Dagoneau N, Samples JR, Le Merrer M, Collod-Beroud G, Boileau C, Munnich A, Cormier-Daire V. 2003. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet 40:34-36.
14. Finkbohner R, Johnston D, Crawford ES, Coselli J, Milewicz DM. 1995. Marfan syndrome. Long-term survival and complications after aortic aneurysm repair. Circulation 91:728-733.
15. Francke U, Berg MA, Tynan K, Brenn T, Liu W, Aoyama T, Gasner C, Miller DC, Furthmayr H. 1995. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet 56:1287-1296.
16. Glick BN, Roberts WC. 1994. Congenitally bicuspid aortic valve in multiple family members. Am J Cardiol 73:400-404.
17. Guo D, Hasham S, Kuang SQ, Vaughan CJ, Boerwinkle E, Chen H, Abuelo D, Dietz HC, Basson CT, Shete SS, Milewicz DM. 2001. Familial thoracic aortic aneurysms and dissections: Genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103:2461-2468.
18. Gupta PA, Putnam EA, Carmical SG, Kaitila I, Steinmann B, Child A, Danesino C, Metcalfe K, Berry SA, Chen E, Delorme CV, Thong MK, Ades LC, Milewicz DM. 2002. Ten novel FBN2 mutations in congenital contractural arachnodactyly: Delineation of the molecular pathogenesis and clinical phenotype. Hum Mutat 19: 39-48.
19. Gupta PA, Wallis DD, Chin TO, Northrup H, Tran-Fadulu VT, Towbin JA, Milewicz DM. 2004. FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. J Med Genet 41:e56.
20. Hahn RT, Roman MJ, Mogtader AH, Devereux RB. 1992. Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. J Am Coll Cardiol 19:283-288.
21. Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, Sukhatme VP, Guggino WB, Germino GG. 2000. Coassembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 408:990-994.
22. Hasham S, Willing M, Guo D, Muilenberg A, Tran V, He R, Scherer S, Shete S, Milewicz DM. 2003. Mapping a locus for familial thoracic aortic aneurysms and dissections to 3p24-25. Circulation 107:3184-3190.
23. Hirst AEJr, Johns VJJr, Kime SWJr. 1958. Dissecting aneurysm of the aorta: A review of 505 cases. Medicine (Baltimore) 37:217-279.
24. Hollister DW, Godfrey M, Sakai LY, Pyeritz RE. 1990. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med 323:152-159.
25. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA. 1988. Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 319:907-912.
26. Huntington K, Hunter AG, Chan KL. 1997. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol 30:1809-1812.
27. Kakko S, Raisanen T, Tamminen M, Airaksinen J, Groundstroem K, Juvonen T, Ylitalo A, Uusimaa P, Savolainen MJ. 2003. Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families. J Thorac Cardiovasc Surg 126:106-113.
28. Katzke S, Booms P, Tiecke F, Palz M, Pletschacher A, Turkmen S, Neumann LM, Pregla R, Leitner C, Schramm C, Lorenz P, Hagemeier C, Fuchs J, Skovby F, Rosenberg T, Robinson PN. 2002. TGGE screening of the entire FBN1 coding sequence in 126 individuals with marfan syndrome and related fibrillinopathies. Hum Mutat 20:197-208.
29. Khau Van Kien P, Wolf JE, Mathieu F, Zhu LM, Salve N, Lalande A, Bonnet C, Lesca G, Plauchu H, Dellinger A, Nivelon-Chevallier A, Brunotte FO, Jeunemaitre X. 2004. Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: Genetic arguments for a particular pathophysiological entity. Eur J Hum Genet 12:173-180.
30. Kim SJ, Im YH, Markowitz SD, Bang YJ. 2000. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis. Cytokine Growth Factor Rev 11:159-168.
31. Lee B, Godfrey M, Vitale E, Hori H, Mattei MG, Sarfarazi M, Tsipouras P, Ramirez F, Hollister DW 1991. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352:330-334.
32. Lie JT. 1982. Aortic dissection in Turner's syndrome. Am Heart J 103:1077-1080.
33. Lilienfeld DE, Gunderson PD, Sprafka JM, Vargas C. 1987. Epidemiology of aortic aneurysms: I. Mortality trends in the United States, 1951 to 1981. Arteriosclerosis 7:637-643.
34. Lin AE, Lippe BM, Geffner ME, Gomes A, Lois JF, Barton CW, Rosenthal A, Friedman WF. 1986. Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 109:820-826.
35. Lin AE, Garver KL, Allanson J. 1987. Aortic-root dilatation in Noonan's syndrome. N Engl J Med 317:1668-1669.
36. Lindsay JJr. 1988. Coarctation of the aorta, bicuspid aortic valve and abnormal ascending aortic wall. Am J Cardiol 61:182-184.
37. Lindsay JJr. 1997. Diagnosis and treatment of diseases of the aorta. Curr Probl Cardiol 22:485-542.
38. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, Backer JD, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Natl Genet 37:275-281.
39. McKusick VA. 1972. Association of congenital bicuspid aortic valve and Erdheim's cystic medial necrosis. Lancet 1:1026-1027.
40. McKusick VA, Logue RB, Bahson HT. 1957. Association of aortic valvular disease and cystic medial necrosis of the ascending aorta. Circulation 16:188-194.
41. Milewicz DM, Pyeritz RE, Crawford ES, Byers PH. 1992. Marfan syndrome: Defective synthesis, secretion, and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J Clin Invest 89: 79-86.
42. Milewicz DM, Grossfield J, Cao SN, Kielty C, Covitz W, Jewett T. 1995. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 95:2373-2378.
43. Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A. 1996. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 94:2708-2711.
44. Milewicz DM, Chen H, Park ES, Petty EM, Zaghi H, Shashidhar G, Willing M, Patel V 1998. Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. Am J Cardiol 82:474-479.
45. Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N. 2004. Heterozygous TGFBR2 mutations in Marfan syndrome. Natl Genet 36:855-860.
46. Neel BG, Gu H, Pao L. 2003. The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci 28:284-293.
47. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Natl Genet 33:407-411.
48. Ng CM, Cheng A, Myers LA. Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, Dietz HC. 2004. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114:1586-1592.
49. Nicod P, Bloor C, Godfrey M, Hollister D, Pyeritz RE, Dittrich H, Polikar R, Peterson KL. 1989. Familial aortic dissecting aneurysm. J Am Coll Cardiol 13:811-819.
50. Pannu H, Fadulu V, Chang J, Lafont A, Hasham SN, Sparks E, Giampietro PF, Zaleski C, Estrera AL, Safi HJ, Shete S, Willing MC, Raman CS, Milewicz DM. 2005. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112:513-520.
51. Pepin M, Schwarze U, Superti-Furga A, Byers PH. 2000. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type [see comments]. N Engl J Med 342:673-680.
52. Pereira L, D'Alessio M, Ramirez F, Lynch JR, Sykes B, Pangilinan T, Bonadio J. 1993. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet 2:1762.
53. Putnam EA, Zhang H, Ramirez F, Milewicz DM. 1995. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural atachnodactyly. Natl Genet 11: 456-458.
54. Rosenquist TH, Beall AC. 1990. Elastogenic cells in the developing cardiovascular system. Smooth muscle, nonmuscle, and cardiac neural crest. Ann NY Acad Sci 588:106-119.
55. Schievink WI, Mokri B. 1995. Familial aortocervicocephalic arterial dissections and congenitally bicuspid aortic valve. Stroke 26:1935-1940.
56. Shachter N, Perloff JK, Mulder DG. 1984. Aortic dissection in Noonan's syndrome (46 XY turner). Am J Cardiol 54:464-465.
57. Silverman DI, Gray J, Roman MJ, Bridges A, Burton K, Boxer M, Devereux RB, Tsipouras P. 1995. Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. J Am Coll Cardiol 26:1062-1067.
58. Sood S, Eldadah ZA, Krause WL, McIntosh I, Dietz HC. 1996. Mutation in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Natl Genet 12: 209-211.
59. van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M. 2001. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 84:129-137.
60. Vaughan CJ, Casey M, He J, Veugelers M, Henderson K, Guo D, Campagna R, Roman MJ, Milewicz DM, Devereux RB, Basson CT. 2001. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 103:2469-2475.
61. Wenstrup RJ, Murad S, Pinnell SR. 1989. Ehlers-Danlos syndrome type VI: Clinical manifestations of collagen lysyl hydroxylase deficiency. J Pediatr 115:405-409.
62. Wenstrup RJ, Meyer RA, Lyle JS, Hoechstetter L, Rose PS, Levy HP, Francomano CA. 2002. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet Med 4:112-117.